May 1, 2023 | Advocacy, Featured, Research News, Technology Updates, Videos
Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Apr 24, 2023 | Eating, Featured, Research News, Technology Updates
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023. Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Apr 19, 2023 | Featured, Research News
Glucagon me… n=1 experiments with microbolusing Glucagon by Tim Street for Diabettech.com, 4-5 April 2023. Part 1: Setting a Baseline Glucagon is a hormone that is produced by the alpha cells and is critical in maintaining glucose homeostasis. It works with the many...
Apr 17, 2023 | Eating, Exercise, Featured, Foods, Research News, Technology Updates
Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023. ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
Apr 10, 2023 | Eating, Featured, Research News, Technology Updates
Abbott faces Class I recall of 4.2M glucose readers on battery fire risks by Peter Green for MedTechDive.com, 6 April 2023. Abbott has initiated a recall for readers for its FreeStyle Libre glucose monitoring systems, which are at risk of catching fire if improperly...
Apr 5, 2023 | Featured, Foods, Research News
Gut microbiome during infancy may predict future type 1 diabetes by Michael Monostra for Healio.com/endocrinology, 27 March 2023. Children who develop type 1 diabetes may have biomarkers present in the gut microbiome as early as age 1 year, according to a...